What You Should Know: - Today, Sema4, a leader in AI-driven clinical data intelligence, announced that they have partnered with BioSymetrics, to accelerate the advancement of drug discovery and new treatments for patients and pharmaceutical companies. - Together the two will leverage Sema4’s Centrellis®, one of the largest and fastest-growing integrated health information platforms that includes approximately 12 million de-identified clinical records, and Elion, BioSymetrics’
Read More
genomics data
Raising the Bar for COVID-19 Data Integrity and Disease Surveillance
Just a few weeks ago, the mood among technologists in the Coronavirus pandemic remained cautiously optimistic about reopening society with the help of testing data, contact tracing apps, and other IT-enabled resources. But the recent spike in illness – 1.9 million new US cases in July, more than double any other month – is a sobering reboot on a crisis we now understand needs far more IT and data coordination than previously recognized. The emerging consensus among epidemiologists is that
Read More
LunaPBC Raises $4.6M to Fuel Community-Owned Genomic & Health Data Platform
LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, has raised $4.6 million from ARCH Venture Partners, Bain Capital Ventures, F-Prime Capital, Illumina Ventures, and Osage University Partners. The latest round brings the company’s total funding to date to $7.6 million. First Community-Owned Health & DNA Research Platform Founded in 2017 on the belief that health data sharing and community ownership are the new philanthropy, LunaDNA is the first
Read More
7 Trends Accelerating “TechBio” – The Life Sciences and Computer Sciences Convergence
We are now living in what I’m calling the TechBio revolution. That’s not a typo that should read BioTech, but rather a new way of looking at the convergence of technology and biology. TechBio is defined as an engineering-first approach of biological processes for industrial, and other purposes, especially the genetic manipulation of microorganisms for the production of antibiotics, hormones, and so on. A process that uses AI and data-enabled discovery to complement the exploration of
Read More
5 Ways SmartTrials is Advancing Precision Medicine Through Genomics
Foundation Medicine’s Dr. Gaurav Singal shares how his company’s platform is changing the game in clinical trials and bolstering precision medicine through genomics.The evolution may be slow going, but it looks like precision medicine is destined to disrupt many aspects of healthcare, and it’s already demonstrating that transformative power in clinical trials—where patient recruitment and retention have long plagued the process, according to Foundation Medicine’s Dr. Gaurav Singal.“Current
Read More
Genoox Raises $6M to Bring Clinical Genomics to U.S. Medical Centers
Genoox, a genomic analysis startup making it easier for doctors, clinicians and researchers to analyze and act on genetic sequencing results by applying various clinical applications has announced a $6 million investment today, led by Triventures and joined by Inimiti Capital Partners and Glilot Capital Partners. Genetic analysis takes other systems hours, but takes Genoox minutes, enabling clinical genomics to become available to millions who don’t have access to top 10 academic centers.Founded
Read More
Luna DNA Raises $4M for Community-owned Genomic and Medical Research Database
Luna DNA, the first community-owned genomic and medical research database has raised $4 million in funding from lead investors Illumina Ventures and Arch Venture Partners. Additional investors include UK-based Bridgelink Capital; Seattle-based Hemisphere Ventures; and Dr. Aristides Patrinos, a former leader of the Human Genome Project and current advisor to Luna DNA. The startup plans to use the funds to support the next phase in creating Luna’s research platform and engaging a global community
Read More
Genomic Analysis Startup Genoox Raises $6M to Expand in the US Market
Genoox, the genomic analysis company making it easier for doctors, clinicians, and researchers to analyze and act on genetic sequencing data has raised $6 million in funding led by Inimiti Capital Partners and Glilot Capital Partners. With this investment, Genoox will also be expanding their genomic services into the U.S. healthcare market, providing medical facilities with innovative solutions to help solve real and pressing healthcare problems. Genoox has an international footprint, with a
Read More
Mount Sinai Spinout Sema4 Launches to Revolutionize Clinical Diagnostics
Sema4, a new startup that has spun out of Mount Sinai Health System has officially launched today that aims to use genomic and clinical data to empower more informed health decisions and enhance care and wellness. Formerly the Mount Sinai Genetic Testing Lab at the Icahn School of Medicine at Mount Sinai, Sema4 is constructing a more comprehensive picture of health by combining a wealth of clinical experience that informs the answers that patients and providers are seeking, the world-class
Read More
Genos Unveils Crowdsourcing Platform for Genomics R&D
Genos, a community for personal genetic discovery and research has announced the public launch of its crowdsourcing platform for genomics research and development. The Genos platform will enable individuals to sequence their genetic profiles with 50 times more data than current popular sequencing options, while empowering individuals to participate in groundbreaking research projects on their own terms. As part of the platform launch, Genos revealed several initial research partners and
Read More
